AI assistant
Sending…
RESEARCH FRONTIERS INC — Director's Dealing 2020
Feb 24, 2020
34569_dirs_2020-02-24_0b66efba-b2d0-4d01-b40a-d4be5cc3dd8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESEARCH FRONTIERS INC (REFR)
CIK: 0000793524
Period of Report: 2020-02-21
Reporting Person: VAN VOORHEES SETH (CFO & VP-Business Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-21 | Common Stock | F | 13717 | $1.83 | Acquired | 152617 | Direct |
| 2020-02-21 | Common Stock | F | 22158 | $1.06 | Acquired | 174775 | Direct |
| 2020-02-21 | Common Stock | F | 45272 | $1.00 | Acquired | 220047 | Direct |
| 2020-02-21 | Common Stock | F | 5746 | $2.89 | Acquired | 225793 | Direct |
| 2020-02-21 | Common Stock | F | 4661 | $3.11 | Acquired | 230454 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-21 | Stock Option (right to buy) | $1.83 | M | 25000 | Disposed | 2026-12-30 | Common Stock (25000) | Direct |
| 2020-02-21 | Stock Option (right to buy) | $1.06 | M | 30000 | Disposed | 2027-12-30 | Common Stock (30000) | Direct |
| 2020-02-21 | Stock Option (right to buy) | $1.00 | M | 60091 | Disposed | 2028-04-18 | Common Stock (60091) | Direct |
| 2020-02-21 | Stock Option (right to buy) | $2.89 | M | 20000 | Disposed | 2029-06-12 | Common Stock (20000) | Direct |
| 2020-02-21 | Stock Option (right to buy) | $3.11 | M | 20000 | Disposed | 2029-12-31 | Common Stock (20000) | Direct |
Footnotes
F1: Represents payment of $257,641 aggregate exercise price of these options by the reduction of securities issued by 63,537 shares, resulting in a net issuance of 91,554 shares.
More from RESEARCH FRONTIERS INC
Interim / Quarterly Report
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 30
Annual Report
2026
Mar 19
Annual Report
2026
Mar 5
Regulatory Filings
2026
Feb 18
Director's Dealing
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2026
Jan 5
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Oct 17